Matches in Nanopublications for { ?s ?p "[Increased activity of PDE5 (and perhaps also PDE9) in glomeruli and in cells of collecting ducts in sodium-retaining states, such as nephrotic syndrome, accounts for renal resistance to atriopeptin; diminished ability to excrete sodium can be corrected by administration of the selective PDE5 inhibitor zaprinast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion description "[Increased activity of PDE5 (and perhaps also PDE9) in glomeruli and in cells of collecting ducts in sodium-retaining states, such as nephrotic syndrome, accounts for renal resistance to atriopeptin; diminished ability to excrete sodium can be corrected by administration of the selective PDE5 inhibitor zaprinast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_provenance.
- assertion description "[Increased activity of PDE5 (and perhaps also PDE9) in glomeruli and in cells of collecting ducts in sodium-retaining states, such as nephrotic syndrome, accounts for renal resistance to atriopeptin; diminished ability to excrete sodium can be corrected by administration of the selective PDE5 inhibitor zaprinast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1413099.RAj_ujrb67JO8beJEoAUxQnwp1x7M28I-mlUP-hkARdSo130_assertion description "[Increased activity of PDE5 (and perhaps also PDE9) in glomeruli and in cells of collecting ducts in sodium-retaining states, such as nephrotic syndrome, accounts for renal resistance to atriopeptin; diminished ability to excrete sodium can be corrected by administration of the selective PDE5 inhibitor zaprinast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1413099.RAj_ujrb67JO8beJEoAUxQnwp1x7M28I-mlUP-hkARdSo130_provenance.
- NP801033.RAHQyCUfFCi77jE3t3OP0kETTNrTjDtSuww2TSI5I41t4130_assertion description "[Increased activity of PDE5 (and perhaps also PDE9) in glomeruli and in cells of collecting ducts in sodium-retaining states, such as nephrotic syndrome, accounts for renal resistance to atriopeptin; diminished ability to excrete sodium can be corrected by administration of the selective PDE5 inhibitor zaprinast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801033.RAHQyCUfFCi77jE3t3OP0kETTNrTjDtSuww2TSI5I41t4130_provenance.